TMEM100, A Regulator Of TRPA1-TRPV1 Interaction, Contributes To Temporomandibular Disorder Pain In Mice

Peng Wang,Qiaojuan Zhang,Fabiana C. Dias,Abbie Suttle,Xinzhong Dong,Yong Chen

DOI: https://doi.org/10.1016/j.jpain.2023.02.126

2023-04-01

Abstract:Temporomandibular disorder (TMD) pain is the most common form of orofacial pain. There is an unmet need to identify new therapeutic targets for TMD pain because current treatments are limited and unsatisfactory. TMEM100, a two-transmembrane protein, was recently identified as a regulator to weaken the TRPA1-TRPV1 physical association, resulting in disinhibition of TRPA1 activity in primary sensory neurons. Interestingly, recent studies have also shown that Tmem100, Trpa1, and Trpv1 mRNAs were upregulated in trigeminal ganglion (TG) after inflammation of temporomandibular joint (TMJ) associated tissues. These findings raise a critical question regarding whether TMEM100 in TG sensory neurons is involved in TMD pain via regulating the functional interaction of TRPA1-TRPV1. Here, using two mouse models of TMD pain induced by TMJ inflammation or masseter muscle injury, we found that global knockout or systemic inhibition of TRPA1 and TRPV1 attenuated pain. In line with their increased genes, mice exhibited significant upregulation of TMEM100, TRPA1, and TRPV1 at the protein levels in TG neurons after TMD pain. Importantly, TMEM100 co-expressed with TRPA1 and TRPV1 and their co-expression was increased in TG neurons-innervating the TMJ and masseter muscle after TMD pain. Moreover, an enhanced activity of TRPA1 in TG neurons evoked by TMJ inflammation or masseter muscle injury was abolished by inhibition of TMEM100. Selective deletion of Tmem100 in TG neurons or local administration of TMEM100 inhibitor into TMJ or masseter muscle attenuated TMD pain. Together, these results suggest that TMEM100 in TG neurons contributes to TMD pain by regulating the interplay of TRPA1-TRPV1. DE027454 and DE027454-02S2.

neurosciences,clinical neurology